Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 5/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.56 |
| ▸ | MAPT | P10636 | 3/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.49 |
| ▸ | MEN1 | O00255 | 2/20 | 0.49 |
| ▸ | GMNN | O75496 | 2/20 | 0.49 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.49 |
| ▸ | BLM | P54132 | 2/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.49 |
| ▸ | NR1H4 | Q96RI1 | 2/20 | 0.49 |
| ▸ | TP53 | P04637 | 1/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.49 |
| ▸ | PRKCA | P17252 | 1/20 | 0.49 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.49 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.49 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9406999 | 1.00 | LMNA (0.59) | LMNAMAPK1MAPTALDH1A1CYP1A2 | |
| SCHEMBL7507925 | 1.00 | LMNA (0.59) | LMNAMAPK1MAPTALDH1A1CYP1A2 | |
| SCHEMBL9406782 | 1.00 | LMNA (0.59) | LMNAMAPK1MAPTALDH1A1CYP1A2 | |
| SCHEMBL9406778 | 1.00 | LMNA (0.59) | LMNAMAPK1MAPTALDH1A1CYP1A2 | |
| SCHEMBL9195199 | 1.00 | LMNA (0.59) | LMNAMAPK1MAPTALDH1A1CYP1A2 | |
| SCHEMBL11909127 | 1.00 | LMNA (0.59) | LMNAMAPK1MAPTALDH1A1CYP1A2 | |
| SCHEMBL4204474 | 1.00 | LMNA (0.59) | LMNAMAPK1MAPTALDH1A1CYP1A2 | |
| SCHEMBL4311172 | 1.00 | LMNA (0.59) | LMNAMAPK1MAPTALDH1A1CYP1A2 | |
| SCHEMBL9218791 | 1.00 | LMNA (0.59) | LMNAMAPK1MAPTALDH1A1CYP1A2 | |
| SCHEMBL2679977 | 1.00 | LMNA (0.59) | LMNAMAPK1MAPTALDH1A1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7960523-B2 | Processes for the production of aminoalkyl glucosaminide phosphate and disaccharide immunoeffectors, and intermediates therefor | CORIXA CORPORATION (US) | 2011-06-14 | — | — | US | disclosed |
| US-20080033155-A1 | PROCESSES FOR THE PRODUCTION OF AMINOALKYL GLUCOSAMINIDE PHOSPHATE AND DISACCHARIDE IMMUNOEFFECTORS, AND INTERMEDIATES THEREFOR | CORIXA CORPORATION (US) | 2008-02-07 | — | — | US | disclosed |
| US-7288640-B2 | Processes for the production of aminoalkyl glucosaminide phosphate and disaccharide immunoeffectors, and intermediates therefor | CORIXA CORPORATION (US) | 2007-10-30 | — | — | US | disclosed |
| WO-2006012425-A2 | PROCESSES FOR THE PRODUCTION OF AMINOALKYL GLUCOSAMINIDE PHOSPHATE AND DISACCHARIDE IMMUNOEFFECTORS, AND INTERMEDIATES THEREFOR | CORIXA CORPORATION (US) | 2006-02-02 | — | — | WO | disclosed |
| US-20050107600-A1 | Processes for the production of aminoalkyl glucosaminide phosphate and disaccharide immunoeffectors, and intermediates therefor | CORIXA CORPORATION, A CORPORATION OF THE STATE OF DELAWARE (US) | 2005-05-19 | — | — | US | disclosed |
| US-5352811-A | To produce homoallylic alcohol, acylation, oxidation of double bond | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1994-10-04 | — | — | US | disclosed |
| US-5278300-A | Pharmaceuticals with immunopotentiation, antitumor, mitogenic, tumor necrosis factor-inducing, interferon-inducing activity; low toxicity | JAPAN TOBACCO, INC. (JP) | 1994-01-11 | — | — | US | disclosed |
| US-5158941-A | Lipid A analog as stimulant for production of interleukin-1 in human monocytes and tumor cell growth inhibitor | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1992-10-27 | — | — | US | disclosed |
| US-4746742-A | IMMUNOLOGY, ANTI-TUMOR | TOHO YAKUHIN KOGYO KABUSHIKI KAISHA (JP) | 1988-05-24 | — | — | US | disclosed |
| EP-0224260-A2 | Analogs of nonreducing monosaccharide moiety of lipid A | Toho Yakuhin Kogyo Kabushiki Kaisha (JP) | 1987-06-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050107600-A1 | Processes for the production of aminoalkyl glucosaminide phosphate and disaccharide immunoeffectors, and intermediates therefor | DDOST, AGL, GALE | LMNA 4696/4885MAPK1 3417/4885MAPT 4448/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.